Revvity Newsroom

Citi Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $145

Moomoo NewsDec 18 07:31 ET

Revvity's Strategic Market Position and Anticipated Growth Drive Buy Rating

TipRanksDec 18 06:48 ET

Revvity Analyst Ratings

BenzingaDec 13 12:03 ET

BofA Securities Upgrades Revvity(RVTY.US) to Buy Rating, Announces Target Price $138

Moomoo NewsDec 13 08:32 ET

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Revvity (RVTY) and McKesson (MCK)

TipRanksDec 6 01:03 ET

Stifel Nicolaus Remains a Hold on Revvity (RVTY)

TipRanksNov 28 02:50 ET

Revvity Is Maintained at Overweight by Barclays

Dow JonesNov 25 09:51 ET

Revvity Analyst Ratings

BenzingaNov 25 09:42 ET

Barclays Maintains Revvity(RVTY.US) With Buy Rating, Cuts Target Price to $135

Moomoo NewsNov 25 07:39 ET

Barclays Adjusts Price Target on Revvity to $135 From $140, Keeps Overweight Rating

MT NewswiresNov 25 06:56 ET

Revvity (RVTY) Receives a Buy From Barclays

TipRanksNov 25 06:37 ET

Strategic Growth and Innovation Drive Puneet Souda's Buy Rating for Revvity

TipRanksNov 25 00:49 ET

TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $144

Moomoo NewsNov 22 07:31 ET

Revvity (RVTY) Gets a Buy From TD Cowen

TipRanksNov 22 07:27 ET

Nephron Downgrades Revvity(RVTY.US) to Sell Rating, Cuts Target Price to $105

Moomoo NewsNov 11 11:31 ET

Revvity's Resilience and Growth Potential: A Buy Rating Amidst Challenges

TipRanksNov 6 03:19 ET

Raymond James Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $146

Moomoo NewsNov 5 10:31 ET

Raymond James Adjusts Price Target on Revvity to $146 From $144, Maintains Outperform Rating

MT NewswiresNov 5 10:09 ET

TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $144

Moomoo NewsNov 5 08:38 ET

Bernstein Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $145

Moomoo NewsNov 5 08:38 ET